Mental Health, one in ten children in this country suffers from a mental disorder severe enough to cause some level of social, behavioral, and/or academic impairment, yet fewer than one in five children with a psychiatric illness receives treatment. Those that are treated often receive psychotropic medication that has not been thoroughly tested for safety and efficacy in children.
Bipolar disorder is one example of a serious illness that has not been adequately characterized in children. The term "bipolar disorder" describes a spectrum of chronic, debilitating psychiatric illnesses. It is characterized by mood episodes that can alternate from extreme highs (mania) to lows (depression) within hours or days, or even months and years. Symptoms of bipolar disorder can interfere with a child's developmentally appropriate functioning at home, at school, and with peers. Children with bipolar disorder are at risk for academic failure, addiction, and even suicide.
The Child & Adolescent Bipolar Foundation (CABF) estimates that at least 750,000 American children and teenagers currently suffer from bipolar disorder. The majority of these young people are undiagnosed. According to CABF (www.bpkids.org), bipolar disorder is believed to occur in approximately one to two percent of the adolescent and adult population; bipolar spectrum disorder and related conditions (such as recurrent depression) occurs in five to seven percent of the same population. While the exact prevalence among younger children is unknown, the number being diagnosed with bipolar disorder is increasing as pediatricians and other professionals who work with children begin to recognize signs of the illness. Bipolar disorder may be particularly difficult to diagnosis in children and adolescents because its symptoms can be hard to distinguish from symptoms of other problems that may occur in these age groups. Childhood conditions such as attention deficit hyperactivity disorder (ADHD), conduct disorder, oppositional defiant disorder, as well as other types of mental illnesses that are more common among adults (major depression or schizophrenia) often present similar symptoms.
Despite the challenges associated with accurate diagnosis and the limited research on the safety and efficacy of medications in children, research shows that, in the last decade, there has been a dramatic increase in the number of officebased visits by children and adolescents that included a prescription for psychotropic medications.
1 This increase is likely due, in part, to the availability of new, putatively safer medications. Additionally, access to and duration of inpatient psychiatric treatment for children and adolescents is declining.
Physicians are turning to psychotropic agents to treat a severely ill group of children and adolescents.
Most child mental health practitioners, advocates, and researchers agree that more research is needed to help ensure that young people suffering from bipolar and other psychiatric disorders are properly diagnosed and safely treated. Our goal is to build and enhance connections among research, policy, and educational initiatives at the University and with the community. The Schubert Center's focus is on children and childhood from infancy through adolescence in local, national, and international contexts.
Dr. Robert Findling is attracting national and international attention for his work on pediatric bipolar disorder. His research goals include understanding the risk factors or precursors to pediatric bipolar disorder, accurately diagnosing the disorder, and identifying effective and safe treatments.
He recently received $21 million in funding from the National Institutes of Health (NIH) to carry out research studies in these areas. 
